Harmony Biosciences Holdings (HRMY)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Operating income (ttm) US$ in thousands 190,826 175,295 178,094 203,640 192,030 199,447 146,839 133,053 120,186 101,204 110,356 100,552 87,529 66,656 55,983
Revenue (ttm) US$ in thousands 710,199 672,548 630,000 585,184 548,499 507,747 476,532 451,378 419,060 383,158 319,980 290,957 268,890 236,824 233,336
Operating profit margin 26.87% 26.06% 28.27% 34.80% 35.01% 39.28% 30.81% 29.48% 28.68% 26.41% 34.49% 34.56% 32.55% 28.15% 23.99%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $190,826K ÷ $710,199K
= 26.87%

The operating profit margin of Harmony Biosciences Holdings has shown fluctuations over the period from June 30, 2021, to December 31, 2024. The operating profit margin started at 23.99% in June 2021 and gradually increased to reach a peak of 39.28% in September 2023. However, there was a decrease in the operating profit margin in the subsequent periods, with a dip to 26.06% by September 30, 2024.

Overall, the trend indicates fluctuations in operating profit margin performance, with a general increase followed by some variability in the latter periods. This could suggest changes in the company's operating efficiency and effectiveness in generating profits from its operations during the analyzed period.